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Chairman: Mohd Rizam Bin Abu Bakar, PhD. 
Faculty: Science. 
 
The work in this thesis is based on the design and analysis of suitable 
compartmental deterministic models for the transmission dynamics of dengue 
fever in a population. A basic dengue model which allows transmission by 
exposed humans and mosquitoes is developed and rigorously analysed. The 
model, consisting of seven mutually-exclusive compartments representing the 
human and vector dynamics, has a locally-asymptotically stable (LAS) disease-
free equilibrium (DFE) whenever a certain epidemiological threshold, known as 
the basic reproduction number (Ro) is less than unity. Further, the model exhibits 
the phenomenon of backward bifurcation, where the stable DFE co-exists with a 
stable endemic equilibrium. The epidemiological consequence of this 
 ii
phenomenon is that the classical epidemiological requirement of making Ro less 
than unity is no longer sufficient, although necessary, for effectively controlling 
the spread of dengue in a community. The model is extended to incorporate an 
imperfect vaccine against the strain of dengue. In both the original and the 
extended models, it is shown, using Lyapunov function theory and LaSalle 
Invariance Principle, that the backward bifurcation phenomenon can be removed 
by substituting the associated standard incidence function with a mass action 
incidence. In other words, in addition to establishing the presence of backward 
bifurcation in models of dengue transmission, this study shows that the use of 
standard incidence in modelling dengue disease causes the backward bifurcation 
phenomenon of dengue disease. 
 
The model is extended to include the dynamics of two strains of dengue disease. 
The extended model has a locally-asymptotically stable, disease-free equilibrium 
(DFE) whenever the maximum of the associated reproduction numbers of the two 
strains (denoted by Ro) is less than unity. It is also shown, using a Lyapunov 
function and LaSalle Invariance Principle, that the DFE of the model, in the 
absence of dengue-induced mortality, is globally-asymptotically stable whenever 
Ro<1. The two strains co-exist if the reproduction number of each strain exceeds 
unity (and are different). For the case when the two reproduction numbers 
exceed unity but are equal, a continuum of co-existence equilibria exists. The 
impact of cross-immunity is explored for the case when Ro >1. It is shown that 
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the model can have infinitely many co-existence equilibria if infection with one 
strain confers complete immunity against the other strain. However, if infection 
with one strain has no effect on susceptibility to the other strain, the model can 
have a unique co-existence equilibrium. It is shown that cross-immunity could 
lead to disease elimination, competitive exclusion or co-existence of the strains. 
Further, the effect of seasonality on dengue transmission dynamics is explored 
using numerical simulations. It is shown that the oscillation pattern differs 
between the strains, both in their subharmonic periods and the relative phase of 
cycles, depending on the degree of the cross-immunity between the strains. 
 
Finally, a deterministic model for monitoring the impact of treatment and vector 
control strategy on the transmission dynamics of dengue in the human and 
vector populations is formulated. In addition to having a locally-asymptotically 
stable disease-free equilibrium (DFE) whenever Ro  is less than unity, it is shown, 
using a Lyapunov function and LaSalle Invariance Principle, and using 
comparison theorem that the DFE of both treatment-free and treatment model, in 
the absence of dengue-induced mortality, is globally-asymptotically stable 
whenever Ro <1; each of the models has a unique endemic equilibrium whenever 
its reproduction number exceed unity. Numerical simulations shows that, the 
use of vector control strategies can result in the effective control of dengue in a 
community by reducing the population of susceptible and exposed mosquitoes. 
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Hasil kerja tesis ini berdasarkan kepada reka bentuk dan analisis terhadap 
kesesuaian model berbahagian ketentuan untuk dinamik penularan demam 
denggi pada populasi. Model asas denggi yang melibatkan penularan oleh 
manusia dan nyamuk yang terdedah dibina dan dianalisis secara rapi. Model ini, 
yang mengandungi tujuh bahagian saling-eksklusif mewakili manusia dan 
dinamik vektor, stabil secara asimptot-setempat (LAS)  keseimbangan bebas-
jangkitan (DFE) bila mana ambang wabak tertentu, yang dikenali sebagai 
nombor asas pembiakan (Ro), kurang dari unitari. Selanjutnya, model 
mempamerkan fenomenon percabangan ke belakang, yang mana kestabilan DFE 
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wujud bersama dengan keseimbangan endemik stabil. Akibat fenomena 
epidemiologi ini yang mana epidemiologi klasik memerlukan Ro < 1 adalah tidak 
lagi cukup, walaupun perlu, untuk mengawal penularan denggi dalam komuniti 
secara berkesan. Model diperluas dengan menggabungkan vaksin yang tidak 
sempurna menentang strain denggi. Menggunakan teori manifold berpusat, 
model yang diperluas juga cenderung untuk mengalami fenomena 
pendwicabangan ke belakang. Dalam kedua-dua model asal dan model yang 
diperluas, ia tertunjuk, menggunakan teori fungsi Lyapunov dan prinsip tak 
varian LaSalle, yang fenomena pendwicabangan ke belakang boleh dihapuskan 
dengan pengantian fungsi kejadian piawai bersekutu dengan insidens tindakan 
jisim. Dengan kata lain, selain dari pengujudan kehadiran percabangan ke 
belakang di dalam model penularan denggi, kajian ini menunjukkan 
penggunaan insidens piawai di dalam pemodelan jangkitan denggi 
menyebabkan fenomena pendwicabangan ke belakang jangkitan denggi. 
 
Model diperluas dengan memasukkan dinamik dua strain jangkitan denggi. 
Model yang diperluas mempunyai kestabilan asimptot-tempatan keseimbangan 
bebas-jangkitan (DFE) bila mana nombor maksimum pembiakan bersekutu oleh 
dua strain (ditandakan oleh Ro) adalah kurang dari unitari. la juga menunjukkan, 
menggunakan fungsi Lyapunov dan prinsip tak varian LaSalle, DFE terhadap 
model, dalam ketiadaan kematian denggi-teraruh, adalah stabil secara asimptot-
sejagat bila mana Ro < 1 . Dua strain wujud bersama jika nombor pembiakan 
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setiap strain melebihi unitari (dan berbeza). Untuk kes, apabila kedua-dua 
nombor pembiakan melebihi unitari dan sama, wujud kontinum kewujudan 
bersama. Kesan keimunan-silang diterokai untuk kes apabila Ro > 1. Ia 
menunjukkan model boleh mempunyai keseimbangan wujud bersama tak 
terhingga banyak jika jangkitan dengan satu strain saling keimunan sepenuhnya 
terhadap strain yang lain. Walau bagaimana pun, jika jangkitan dengan satu 
strain tidak mempunyai kesan terhadap rentanan terhadap strain yang lain, 
model boleh mempunyai keseimbangan kewujudan-bersama yang unik. Ia 
tertunjuk bahawa keimunan-silang boleh menyebabkan penghapusan wabak 
penyakit, penghapusan secara kompetitif atau kewujudan-bersama wabak. 
Seterusnya, kesan bermusim bagi dinamik penularan denggi dijelajahi 
menggunakan simulasi berangka. Ia menunjukkan pola gerakan berkala tidak 
sama antara dua strain, kedua-dua di dalam tempoh subharmonik dan kitaran 
fasa relatif, bergantung kepada darjah keimunan-silang di antara dua strain. 
 
Akhir sekali, model ketentuan untuk pengawasan kesan rawatan dan strategi 
kawalan vektor terhadap penularan dinamik denggi terhadap manusia dan 
populasi vektor dirumus. Selain mempunyai kestabilan asimptot-tempatan 
keseimbangan bebas-jangkitan (DFE) bila mana Ro kurang dari unitari, ia 
tertunjuk, menggunakan fungsi Lyapunov dan prinsip tak varian LaSalle dan 
mengunakan teori perbandingan yang mana DFE bagi kedua-dua model bebas 
rawatan dan model rawatan, di dalam ketidak hadiran kematian denggi-teraruh, 
 vii
stabil secara asimptotik-sejagat apabila Ro < 1; setiap model mempunyai 
keseimbangan endemik unik apabila nombor pertumbuhan melebihi unitari. 
Simulasi berangka menunjukkan, penggunaan strategi kawalan vektor boleh 
membawa kepada kawalan denggi yang efektif di dalam komuniti dengan 
mengurangkan populasi nyamuk yang rentan dan yang terdedah kepada denggi.               
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CHAPTER 1
INTRODUCTION
1.1 Introduction
Dengue, a mosquito-transmitted disease caused by any of four closely-related
virus serotypes (DEN-1, DEN-2, DEN-3 and DEN-4) of the genus Flavivirus, is
endemic in at least 100 countries in Africa, the Americas, the Eastern Mediter-
ranean and subtropical regions of the world [35, 107], inhibited by over 2.5 billion
people. Dengue ranks second to malaria amongst deadly mosquito-borne dis-
eases, each year claiming about 100 million infections and 20,000 deaths globally
[107]. Classical dengue fever causes relatively mild morbidity and mortality, and
sufferers recover within one to two weeks after the onset of fever [63]. However,
some individuals develop dengue hemorrhagic fever (DHF) or dengue shock syn-
drome (DSS) [71], where the severity of the disease is drastically increased (with
mortality ranging from 5-15%) [63, 79]. Figures from the World Health Organi-
zation show that hundreds of thousands of cases of DHF are recorded annually
[16, 17, 117].
Dengue is transmitted to humans through mosquito bites. Female mosquitoes
(of the genus Aedes (Stegomyia), mainly the Aedes aegypti [9]) acquire infection
by taking a blood meal from an infected human (in the viremic phase of illness).
These mosquitoes, after becoming infectious, then pass the disease to suscep-
1
tible humans. Individuals who recover from one serotype become permanently
immune to it, but may become partially-immuned or temporarily-immuned (or
both) to the other serotypes [117].
Unfortunately, there is still no specific effective treatment for dengue. Per-
sons with dengue fever should rest and drink plenty of fluids. They should be
kept away from mosquitoes for the protection of others [30, 44]. Dengue hemor-
rhagic fever is treated by replacing lost fluids. Some patients need transfusions
to control bleeding.
Although there is no effective and safe vaccine for dengue at the moment, a
number of candidate vaccines (including live attenuated mono- and tetra-valent
formulation, inactivated whole virus vaccines, and recombinant subunit vac-
cines) are undergoing various phases of clinical trials ([16, 17, 30, 31, 45, 73,
84, 104, 117, 118]) However, it is believed that any future dengue vaccine would
not be able to offer perfect protection against all serotypes. Thus, any future
dengue vaccine is expected to be imperfect [31]. Efficacy trials in human vol-
unteers have yet to be initiated. Research is also being conducted to develop
second-generation recombinant vaccine viruses. Therefore, an effective dengue
vaccine for public use will not be available for 5 to 10 years. Prospects for
reversing the recent trend of increased epidemic activity and geographic expan-
sion of dengue are not promising. New dengue virus strains and serotypes will
likely continue to be introduced into many areas where the population densities
2
